Business Context and Reporting Period
Company: Science Applications International Corporation (SAIC)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three and six months ended August 2, 2024 (Fiscal 2025 Q2)
Business Overview: SAIC is a leading provider of technical, engineering, and enterprise IT services primarily to the U.S. government. Effective February 3, 2024, the company reorganized into two reportable segments: Defense and Intelligence and Civilian, supported by the Innovation Factory. Approximately 98% of revenues are derived from U.S. government contracts.
Key Financial Metrics
| Metric (in millions) | Three Months Ended Aug 2, 2024 |
Three Months Ended Aug 4, 2023 |
Six Months Ended Aug 2, 2024 |
Six Months Ended Aug 4, 2023 |
|---|---|---|---|---|
| Revenues | $1,818 | $1,784 | $3,665 | $3,812 |
| Operating Income | $134 | $362 | $265 | $519 |
| Operating Margin | 7.4% | 20.3% | 7.2% | 13.6% |
| Net Income | $81 | $247 | $158 | $345 |
| Diluted EPS | $1.58 | $4.56 | $3.06 | $6.35 |
| Operating Cash Flow | N/A | N/A | $236 | $232 |
| Total Debt (Principal) | $2,177 | N/A | N/A | N/A |
| Cash & Equivalents | $48 | N/A | N/A | N/A |
Note: Debt figures represent principal balances as of August 2, 2024. Cash flow data is presented for the six-month period only.
Material Changes vs. Prior Period
- Revenue: Q2 revenue increased 2% ($34 million) year-over-year due to volume ramp-up on existing and new contracts. However, six-month revenue decreased 4% ($147 million), primarily due to the sale of the Supply Chain Business in the prior year ($188 million impact) and contract completions. Adjusted for the divestiture, six-month revenue grew 1.1%.
- Operating Income: Operating income declined significantly (63% in Q2, 49% in six months) compared to the prior year. This decrease is largely attributable to the non-recurrence of a $234 million gain on the sale of the Supply Chain Business recognized in the prior year.
- Segment Performance:
- Defense and Intelligence: Q2 revenue up 2%; six-month revenue down 5% (excluding divestiture impact, up 1.9%). Operating income remained stable in Q2 but declined 7% over six months.
- Civilian: Q2 revenue up 2%; six-month revenue down 1%. Operating income margins compressed in both periods due to volume mix and reduced volume on existing contracts.
- Debt Structure: In February 2024, the company executed a Sixth Amendment to its Credit Agreement, establishing a $510 million Term Loan B3 Facility (due 2031) to refinance maturing Term Loan B and B2 facilities.
Guidance, Outlook, and Risks
- Backlog: Total backlog stood at $22.9 billion as of August 2, 2024, consisting of $4.2 billion in funded backlog and $18.7 billion in negotiated unfunded backlog. Net bookings were estimated at $1.2 billion for the quarter and $3.8 billion for the six months.
- Outlook: Management expects to recognize approximately 79% of remaining performance obligations ($5.4 billion) over the next 12 months. The company anticipates continued competition and pricing pressure but believes its scale and prime contractor status position it well for large opportunities.
- Risks and Contingencies:
- Government Funding: Reliance on U.S. government spending creates exposure to budget delays, continuing resolutions, or potential shutdowns if FY2025 appropriations are not passed by September 2024.
- Legal Proceedings: The company is cooperating with a U.S. Department of Justice Antitrust Division investigation (subpoenas issued in 2022 and 2023). Management cannot currently estimate potential fines or penalties.
- Contract Audits: Ongoing indirect cost audits by the Defense Contract Audit Agency (DCAA) could result in disallowance of costs or penalties if reserves are insufficient.
- Capital Allocation: The company repurchased approximately $204 million of stock in Q2 and $285 million in the first six months. A quarterly dividend of $0.37 per share was declared and paid.
Investor Verification Checklist
- Divestiture Impact: Verify the extent to which the prior year's $234 million gain on the Supply Chain Business sale distorts year-over-year profitability comparisons.
- Backlog Quality: Assess the ratio of funded ($4.2B) vs. unfunded ($18.7B) backlog to gauge revenue visibility and exposure to government funding delays.
- Debt Refinancing: Review the terms of the new Term Loan B3 Facility and the company's leverage ratios to ensure compliance with covenants.
- Legal Exposure: Monitor updates regarding the DOJ Antitrust investigation and the status of the AAV contract termination negotiations.
- Contract Mix: Analyze the shift in contract types (Cost Reimbursement vs. Firm-Fixed Price) and its impact on margin stability, particularly following the divestiture of the Supply Chain Business.